Abstract:Background: Methamphetamine induces neuronal N-acetyl-aspartate synthesis in preclinical studies. In a preliminary human proton magnetic resonance spectroscopic imaging investigation, we also observed that N-acetyl-aspartate+N-acetyl-aspartyl-glutamate in right inferior frontal cortex correlated with years of heavy methamphetamine abuse. In the same brain region, glutamate+glutamine is lower in methamphetamine users than in controls and is negatively correlated with depression. N-acetyl and glutamatergic neurochemistries therefore merit further investigation in methamphetamine abuse and the associated mood symptoms. Methods: Magnetic resonance spectroscopic imaging was used to measure N-acetyl-aspartate+N-acetyl-aspartylglutamate and glutamate+glutamine in bilateral inferior frontal cortex and insula, a neighboring perisylvian region affected by methamphetamine, of 45 abstinent methamphetamine-dependent and 45 healthy control participants. Regional neurometabolite levels were tested for group differences and associations with duration of heavy methamphetamine use, depressive symptoms, and state anxiety. Results: In right inferior frontal cortex, N-acetyl-aspartate+N-acetyl-aspartyl-glutamate correlated with years of heavy methamphetamine use (r = +0.45); glutamate+glutamine was lower in methamphetamine users than in controls (9.3%) and correlated negatively with depressive symptoms (r = -0.44). In left insula, N-acetyl-aspartate+N-acetyl-aspartyl-glutamate was 9.1% higher in methamphetamine users than controls. In right insula, glutamate+glutamine was 12.3% lower in methamphetamine users than controls and correlated negatively with depressive symptoms (r = -0.51) and state anxiety (r = -0.47). Conclusions: The inferior frontal cortex and insula show methamphetamine-related abnormalities, consistent with prior observations of increased cortical N-acetyl-aspartate in methamphetamine-exposed animal models and associations between cortical glutamate and mood in human methamphetamine users.

MiR-124 involves in methamphetamineaddiction in PC12 cells by inhibiting GluR2

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

The potential involvement of miR-204-3p-axon guidance network in methamphetamine-induced locomotor sensitization of mice.

Ago2 and Dicer1 Are Involved in METH-induced Locomotor Sensitization in Mice Via Biogenesis of Mirna

miR-181a is a negative regulator of GRIA2 in methamphetamine-use disorder

Mechanisms Underlying Microrna-222-3p Modulation of Methamphetamine-Induced Conditioned Place Preference in the Nucleus Accumbens in Mice

MicroRNA-181a Is Involved in Methamphetamine Addiction Through the ERAD Pathway

Regulation of Mir‐128 in the Nucleus Accumbens Affects Methamphetamine‐induced Behavioral Sensitization by Modulating Proteins Involved in Neuroplasticity

Regulation of Microrna-29C in the Nucleus Accumbens Modulates Methamphetamine -Induced Locomotor Sensitization in Mice

Potential Ago2/miR-3068-5p Cascades in the Nucleus Accumbens Contribute to Methamphetamine-Induced Locomotor Sensitization of Mice

Mrna Changes in Nucleus Accumbens Related to Methamphetamine Addiction in Mice

Chronic methamphetamine regulates the expression of MicroRNAs and putative target genes in the nucleus accumbens of mice

Impact of miR-29c-3p in the Nucleus Accumbens on Methamphetamine-Induced Behavioral Sensitization and Neuroplasticity-Related Proteins

Rhynchophylline inhibits methamphetamine dependence via modulating the miR-181a-5p/GABRA1 axis

PPARγ/Adiponectin axis attenuates methamphetamine-induced conditional place preference via the hippocampal AdipoR1 signaling pathway

A Novel Microrna, Novel-M009c, Regulates Methamphetamine Rewarding Effects

Methamphetamine Induces Alterations in the Long Non-Coding RNAs Expression Profile in the Nucleus Accumbens of the Mouse.

MicroRNA-31-3p/RhoA signaling in the dorsal hippocampus modulates methamphetamine-induced conditioned place preference in mice

miR-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK/mTOR pathway in Parkinson's disease.

Overview of Long Non-Coding RNA and Mrna Expression in Response to Methamphetamine Treatment in Vitro.

Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.